Diagnostic pet imaging of cardiac amyloidosis
AssigneeTakahiro Higuchi
InventorsTakahiro HIGUCHI, Rudolf Werner
Life of this patent
Estimating the term…
Abstract
A compound or pharmaceutically acceptable salt thereof has at least one bis-phosphonate or bisphosphonate ester group, and a positron emitting radionuclide Po. The positron emitting radionuclide Po is attached to the at least one bisphosphonate or bisphosphonate ester group. The compound may be useful in a method of diagnosis of amyloidosis, such as cardiac amyloidosis.
Claims18
A compound or pharmaceutically acceptable salt thereof for use in a method of diagnosis of cardiac amyloidosis, wherein the compound or pharmaceutically acceptable salt thereof comprises at least one bisphosphonate or bisphosphonate ester group, and
- a positron emitting radionuclide Po, wherein Po is attached to the at least one bisphosphonate or bisphosphonate ester group.
Dependencies are inferred from the claim text.